Projects funded by the NCN
Novel dual PDE4 and PDE7 inhibitors in a group of purine and deazapurine derivatives - perspective for the treatment of autoimmune diseases.
2014/15/B/NZ7/00885
Keywords:
purines dezapurines phosphodiesterases PDE4 PDE7 TNFalfa molecular modeling SAR animal models autoimmune diseases tissue distribution
Descriptors:
- ST5_16:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: OPUS 8 - announced on 2014-09-15
Amount awarded: 595 200 PLN
Project start date (Y-m-d): 2015-07-13
Project end date (Y-m-d): 2018-10-12
Project duration:: 39 months (the same as in the proposal)
Project status: Project settled